Product Details
Product Name:
ABT-080 |
CAS No.:
189498-57-5 |
Purity:
98.15% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | ABT-080 |
Description | ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma. |
In vitro | ABT-080 Inhibits calcium ionophore (A-23187)-stimulated LTB4 formation in human neutrophils with IC50 of 20nM. ABT-080 inhibits LTB4 production with an IC50 of 13000nM in a calcium ionophore-stimulated human whole blood assay. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 50 mg/mL (84.51 mM)
|
Keywords | ABT 080 | ABT-080 |
Inhibitors Related | Montelukast sodium | L 651896 | L 674573 | REV 5901A | LY255283 | RG 7152 | Pranlukast | Montelukast | Nedocromil | CGP 35949 | MK-571 sodium | Masilukast |
Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:948845-91-8
$195.00 / 1mg
-
CAS:1235560-28-7
$44.00 / 1mg
-
CAS:460746-46-7
$40.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-10-16 |
|
$10.00/1ASSAYS |
VIP4Y
|
Dorne Chemical Technology co. LTD
|
2024-03-26 |
|
$0.00/1G |
VIP1Y
|
CONTIDE BIOTECH CO.,LTD
|
2024-04-15 |